Cargando…
Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor
Prostate cancer is a major cause of death in males. Cyproterone acetate (CPA), the steroidal anti-androgen for part of androgen deprivation therapy, may block the androgen-receptor interaction and then reduce serum testosterone through its weak anti-gonadotropic action. In addition to CPA inducing h...
Autores principales: | Chen, Chih-Shou, Gao, Guan-Lun, Ho, Dong-Ru, Lin, Chih-Yi, Chou, Yu-Ting, Chen, Shan-Chun, Huang, Min-Cong, Kao, Wen-Ya, Su, Jyan-Gwo Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943802/ https://www.ncbi.nlm.nih.gov/pubmed/33750846 http://dx.doi.org/10.1038/s41598-021-84769-7 |
Ejemplares similares
-
Voltammetric Determination of Cyproterone Acetate in Pharmaceutical Preparations
por: El-Enany, Nahed, et al.
Publicado: (2010) -
A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.
por: Keating, J. J., et al.
Publicado: (1989) -
Unilateral proptosis and blindness caused by meningioma in a patient treated with cyproterone acetate
por: Sys, Celine, et al.
Publicado: (2015) -
Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014) -
SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment
por: Korpaisarn, Sira, et al.
Publicado: (2023)